Victory Capital Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
AAA
S
WP
6CM
Victory Capital Management's ANAB Position: Q2 2026 in Review
Victory Capital Management increased its AnaptysBio (ANAB) stake by 56% in Q2 2026, buying an estimated $3.7M and bringing the position to 169,227 shares worth $11.4M. The position accounts for 0.01% of the portfolio, ranked #1073.
Victory Capital Management first reported a position in ANAB in Q3 2019 and has held it in 16 quarters since. The position peaked at $11.8M in Q2 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.
- Victory Capital Management held 169,227 shares of AnaptysBio worth $11.4M as of Q2 2026.
- Victory Capital Management bought 61,024 AnaptysBio shares in Q2 2026, an estimated $3.7M.
- AnaptysBio made up 0.01% of Victory Capital Management's portfolio in Q2 2026, its #1073 holding.
- Victory Capital Management first reported a position in AnaptysBio in Q3 2019 and has held it in 16 quarters since.
- Victory Capital Management's AnaptysBio position peaked at $11.8M in Q2 2025.
- 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.
Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.